These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 22227673)

  • 21. Type 1 diabetes vaccine candidates promote human Foxp3(+)Treg induction in humanized mice.
    Serr I; Fürst RW; Achenbach P; Scherm MG; Gökmen F; Haupt F; Sedlmeier EM; Knopff A; Shultz L; Willis RA; Ziegler AG; Daniel C
    Nat Commun; 2016 Mar; 7():10991. PubMed ID: 26975663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonoverlapping roles of PD-1 and FoxP3 in maintaining immune tolerance in a novel autoimmune pancreatitis mouse model.
    Zhang B; Chikuma S; Hori S; Fagarasan S; Honjo T
    Proc Natl Acad Sci U S A; 2016 Jul; 113(30):8490-5. PubMed ID: 27410049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD4+Foxp3+ regulatory T cells in the control of autoimmunity: in vivo veritas.
    Piccirillo CA; d'Hennezel E; Sgouroudis E; Yurchenko E
    Curr Opin Immunol; 2008 Dec; 20(6):655-62. PubMed ID: 18926906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Foxp3+ regulatory T cells: selfishness under scrutiny.
    Stephens GL; Shevach EM
    Immunity; 2007 Sep; 27(3):417-9. PubMed ID: 17892850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repression of the genome organizer SATB1 in regulatory T cells is required for suppressive function and inhibition of effector differentiation.
    Beyer M; Thabet Y; Müller RU; Sadlon T; Classen S; Lahl K; Basu S; Zhou X; Bailey-Bucktrout SL; Krebs W; Schönfeld EA; Böttcher J; Golovina T; Mayer CT; Hofmann A; Sommer D; Debey-Pascher S; Endl E; Limmer A; Hippen KL; Blazar BR; Balderas R; Quast T; Waha A; Mayer G; Famulok M; Knolle PA; Wickenhauser C; Kolanus W; Schermer B; Bluestone JA; Barry SC; Sparwasser T; Riley JL; Schultze JL
    Nat Immunol; 2011 Aug; 12(9):898-907. PubMed ID: 21841785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonself-antigens are the cognate specificities of Foxp3+ regulatory T cells.
    Pacholczyk R; Kern J; Singh N; Iwashima M; Kraj P; Ignatowicz L
    Immunity; 2007 Sep; 27(3):493-504. PubMed ID: 17869133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of viruses in the loss of tolerance to self-antigens and in autoimmune diseases.
    von Herrath MG; Oldstone MB
    Trends Microbiol; 1995 Nov; 3(11):424-30. PubMed ID: 8574515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3rd Keystone Symposium on T regulatory cells.
    McMurchy AN; Levings MK
    Immunotherapy; 2009 Jul; 1(4):529-37. PubMed ID: 20635985
    [No Abstract]   [Full Text] [Related]  

  • 29. Regulatory T-cell adoptive immunotherapy: potential for treatment of autoimmunity.
    Wright GP; Ehrenstein MR; Stauss HJ
    Expert Rev Clin Immunol; 2011 Mar; 7(2):213-25. PubMed ID: 21426259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Taking regulatory T cells into medicine.
    Sakaguchi S
    J Exp Med; 2021 Jun; 218(6):. PubMed ID: 34037676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differentiation and function of Foxp3(+) effector regulatory T cells.
    Cretney E; Kallies A; Nutt SL
    Trends Immunol; 2013 Feb; 34(2):74-80. PubMed ID: 23219401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early childhood education is critical for T
    Salgado OC; Hogquist KA
    Nat Immunol; 2019 Aug; 20(8):952-954. PubMed ID: 31308543
    [No Abstract]   [Full Text] [Related]  

  • 33. Comment on "Cutting edge: depletion of Foxp3+ cells leads to induction of autoimmunity by specific ablation of regulatory T cells in genetically targeted mice".
    Wolf D; Wolf AM; Tzankov A
    J Immunol; 2010 Apr; 184(8):4051. PubMed ID: 20368283
    [No Abstract]   [Full Text] [Related]  

  • 34. Emerging topics and new perspectives on regulatory and effector T cells.
    Zheng SG
    J Mol Cell Biol; 2012 Feb; 4(1):1-2. PubMed ID: 22140270
    [No Abstract]   [Full Text] [Related]  

  • 35. Autoimmunity: basic mechanisms and implications in endocrine diseases. Part II.
    Ballotti S; Chiarelli F; de Martino M
    Horm Res; 2006; 66(3):142-52. PubMed ID: 16807509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular control of regulatory T cell development and function.
    Kitagawa Y; Sakaguchi S
    Curr Opin Immunol; 2017 Dec; 49():64-70. PubMed ID: 29065384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular mechanisms of regulatory T-cell development.
    Chatila T
    Chem Immunol Allergy; 2008; 94():16-28. PubMed ID: 18802333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoimmune thyroiditis: a model uniquely suited to probe regulatory T cell function.
    Kong YC; Morris GP; Brown NK; Yan Y; Flynn JC; David CS
    J Autoimmun; 2009; 33(3-4):239-46. PubMed ID: 19822405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasticity of T(reg) cells: is reprogramming of T(reg) cells possible in the presence of FOXP3?
    Beyer M; Schultze JL
    Int Immunopharmacol; 2011 May; 11(5):555-60. PubMed ID: 21115121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoimmune hepatitis and antigen-specific T regulatory cells: when can we send in the regulators?
    Vierling JM
    Hepatology; 2011 Feb; 53(2):385-8. PubMed ID: 21274860
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.